GlassScriptPhysician profile
Haley Wilson Jackson
NPI 1396248159
$999.50
in general payments reported to CMS, 2019-2025
14 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.17 · 2021: $99.38 · 2022: $121 · 2023: $263 · 2024: $252 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $685.56 | 2021-2025 | |
| Boston Scientific Corporation | $47.47 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $34.43 | 2021-2022 | |
| Lilly USA, LLC | $32.96 | 2023-2025 | Mounjaro, Jardiance |
| Medtronic, INC. | $32.83 | 2023-2024 | Intellis Adaptivestim |
| Neuronetics, INC. | $29.73 | 2025 | Neurostar Tms Therapy System |
| Biohaven Pharmaceutical Holding Company LTD. | $25.17 | 2022 | |
| Daiichi Sankyo INC. | $19.02 | 2022 | |
| Hologic Sales and Service, LLC | $17.51 | 2023 | Aptima, Thinprep 2000 Processor |
| Mannkind Corporation | $16.17 | 2020 | |
| Organon LLC | $15.99 | 2021 | |
| Pfizer INC. | $15.34 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.88 | 2024 | Trintellix |
| Supernus Pharmaceuticals, INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.